secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086352
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine stockholders elect three Class II directors, approve say-on-pay, ratify EY auditor
--------------------------------------------------------------------------------

- Elected Georges Gemayel, Mark Chin, and Liam Ratcliffe as Class II directors for three-year term ending 2028.
- Non-binding advisory vote approved executive compensation: 30,801,342 for, 235,453 against, 6,286 abstain.
- Stockholders recommended say-on-pay vote every year; board adopted annual frequency until at least 2031.
- Ratified Ernst & Young as independent registered public accounting firm for FY2025: 32,117,099 for, 2,370 against, 488 withheld.
- All proposals passed with majority support; broker non-votes ranged from 1,076,876 on director elections to none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000095017025086352/0000950170-25-086352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000095017025086352/iron-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer